Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 91.75B | 91.85B | 91.47B | 86.39B | 79.47B | 70.37B |
Gross Profit | 49.94B | 50.11B | 49.59B | 45.82B | 42.40B | 38.58B |
EBITDA | 14.39B | 16.68B | 15.75B | 14.92B | 14.90B | 13.22B |
Net Income | 7.55B | 9.58B | 9.07B | 8.91B | 7.62B | 7.12B |
Balance Sheet | ||||||
Total Assets | 105.34B | 99.47B | 100.50B | 92.19B | 92.38B | 92.92B |
Cash, Cash Equivalents and Short-Term Investments | 7.97B | 9.27B | 10.00B | 5.35B | 5.99B | 9.55B |
Total Debt | 51.38B | 47.75B | 44.66B | 39.55B | 40.78B | 44.61B |
Total Liabilities | 86.79B | 81.30B | 81.86B | 74.91B | 76.23B | 79.37B |
Stockholders Equity | 18.42B | 18.04B | 18.50B | 17.15B | 16.04B | 13.45B |
Cash Flow | ||||||
Free Cash Flow | 7.06B | 7.19B | 7.92B | 5.60B | 6.99B | 6.37B |
Operating Cash Flow | 12.19B | 12.51B | 13.44B | 10.81B | 11.62B | 10.61B |
Investing Cash Flow | -8.14B | -5.47B | -5.50B | -2.43B | -3.27B | -11.62B |
Financing Cash Flow | -2.79B | -7.56B | -3.01B | -8.52B | -10.78B | 3.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | 63.40B | 40.55 | ― | ― | 3.70% | -0.53% | |
74 Outperform | $193.08B | 25.85 | 39.88% | 3.91% | -0.34% | -20.51% | |
74 Outperform | 285.98B | 23.64 | 42.62% | 3.03% | 1.34% | 14.67% | |
74 Outperform | 41.36B | 24.62 | 16.70% | 2.47% | 9.65% | -4.26% | |
71 Outperform | 13.38B | 143.04 | 6.30% | ― | 11.85% | -64.69% | |
67 Neutral | 35.66B | 23.51 | 6.15% | 3.50% | 4.63% | -28.22% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |